Researchers have substantially advanced the course of an new treatment for amyloid heart disease, leveraging the investigational drug. Initial trial information reveals significant improvements for individuals diagnosed https://biotech730882.theisblog.com/42551904/bridgebio-progresses-cardiac-amyloidosis-therapy-through-the-therapy